Original research
par
Rigg, Khary K.
Date de publication
2024
Géographie
USA
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
The objective of this study, therefore, was to identify/explain the most salient attitudes toward extended-release naltrexone (XR-NTX; Vivitrol®) as a form of OUD treatment among African Americans.
Constatations/points à retenir
Study findings suggest that African Americans who use opioids may have more favorable attitudes toward XR-NTX than other medications for OUD (e.g., methadone), which tend to be highly stigmatized.
La conception ou méthodologie de recherche
In-depth interviews (n = 30)
Mots clés
Equity
Substitution/OAT
About PWUD
